EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 28 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,464,000 | +80.5% | 35,200 | 0.0% | 0.84% | +53.8% |
| Q2 2016 | $1,365,000 | -4.3% | 35,200 | 0.0% | 0.55% | -7.8% |
| Q1 2016 | $1,426,000 | -54.3% | 35,200 | 0.0% | 0.59% | -32.6% |
| Q4 2015 | $3,121,000 | -64.8% | 35,200 | -70.6% | 0.88% | -48.3% |
| Q3 2015 | $8,876,000 | -22.3% | 119,900 | -15.1% | 1.70% | +57.7% |
| Q2 2015 | $11,426,000 | +68.3% | 141,300 | -12.8% | 1.08% | +68.0% |
| Q1 2015 | $6,790,000 | +119.0% | 162,100 | -19.0% | 0.64% | +115.8% |
| Q4 2014 | $3,100,000 | +22.5% | 200,000 | 0.0% | 0.30% | +13.8% |
| Q3 2014 | $2,530,000 | -11.7% | 200,000 | 0.0% | 0.26% | +6.1% |
| Q2 2014 | $2,866,000 | +12.4% | 200,000 | 0.0% | 0.25% | +18.3% |
| Q1 2014 | $2,550,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |